Table 3.
Reversion and non-reversion of QFT-IT among ESRD patients with 1st QFT-IT positive result
| ESRD patients (N = 39) | Reversion | Non-reversion | OR (95 % CI) | P value | |
|---|---|---|---|---|---|
| Dialysis method | |||||
| PD | 7 (35.0 %) | 13 (65.0 %) | 9.7 (1.1–88.7) | 0.04 | |
| HD | 1 (5.3 %) | 18 (94.7 %) | 1 (Ref.) | ||
| Treatment | |||||
| LTBI treatment | 5 (27.8 %) | 13 (72.2 %) | 2.3 (0.5–11.4) | 0.43 | |
| No LTBI Treatment | 3 (14.3 %) | 18 (85.7 %) | 1 (Ref.) | ||
| Treatment drug | |||||
| Rifampin | 3 (37.5 %) | 5 (62.5 %) | 2.4 (0.3–19.8) | 0.61 | |
| INH | 2 (20.0 %) | 8 (80.0 %) | 1 (Ref.) | ||
OR odds ratio, PD peritoneal dialysis, HD hemodialysis, LTBI latent tuberculosis infection, RFP rifampicin, INH isoniazid